AI Science Tracker
EN

The First Affiliated Hospital of Anhui University of Chinese Medicine

1 discovery from 2026

Discoveries

Multicenter development of an interpretable machine learning model for prognosis of acute pancreatitis with acute kidney injury.

Source check: Source checked. Not independent scientific confirmation.

Finding: A Random Forest model selected from 24 machine-learning models predicted 60-day mortality for acute-pancreatitis patients with acute kidney injury using 18 screened clinical features from MIMIC-IV, with SHAP interpretation and an online application.

Technology: A Random Forest model selected from 24 machine-learning models predicted 60-day mortality for acute-pancreatitis patients with acute kidney injury using 18 screened clinical features from MIMIC-IV, with SHAP interpretation and an online application.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A Random Forest model selected from 24 machine-learning models predicted 60-day mortality for acute-pancreatitis patients with acute kidney injury using 18 screened clinical features from MIMIC-IV, with SHAP interpretation and an online application.
Test and result
The RF model reached AUC 0.8963 in internal validation and 0.8122 in independent eICU validation despite class imbalance and center heterogeneity; prospective randomized utility remains untested.
Limitation / still unknown
The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13754914/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.